Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion type Assertion NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_head.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion description "[The BIOMED-2 group recently validated a set of immunoglobulin heavy chain (IGH) multiplex primers with high sensitivity in B-cell non-Hodgkin lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_provenance.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion evidence source_evidence_literature NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_provenance.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion SIO_000772 18382369 NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_provenance.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion wasDerivedFrom befree-20140225 NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_provenance.
- NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_assertion wasGeneratedBy ECO_0000203 NP545987.RA19_TK7fye7AZ8bVbRSBVB-JdWMSmDopSMxQrLWyKeMg130_provenance.